Scholarlink

Introduction <p>Primary squamous cell carcinoma of the colon is a rare malignancy, especially in the postpartum period. Currently, there are no recommended guidelines for this disease. <i>BRAF</i><sup><i>V600E</i></sup>-mutated metastatic colorectal cancer occurs in approximately 8–12% of patients with colorectal cancer.</p> Case presentation <p>Herein, we report a case of a 37-year-old Chinese woman diagnosed with postpartum descending colon squamous cell carcinoma harboring the <i>BRAF</i><sup><i>V600E</i></sup> mutation, which was treated with radical resection and adjuvant chemotherapy combined with targeted therapy. Eight months later, a new lesion was detected in the colon 40&#xa0;cm away from the first mass. The patient was enrolled in a clinical trial but withdrew following two treatment cycles because of rapid disease progression. Subsequently, the patient died approximately 6 months after enrolling in the trial.</p> Conclusion <p>Squamous cell carcinoma of the colon, particularly in postpartum women, is uncommon and often associated with an advanced stage and poor prognosis. Presently, patients with colorectal cancer carrying the <i>BRAF</i><sup><i>V600E</i></sup> mutation typically exhibit a low ratio, an advanced stage, and limited response to existing treatment approaches, resulting in a poor prognosis. Considerable emphasis and effort must be devoted to colonic squamous cell carcinoma, specifically cases harboring the <i>BRAF</i><sup><i>V600E</i></sup> mutation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Postpartum colonic squamous cell carcinoma with a BRAFV600E mutation: a case report

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月18日

查看全文
  • Qin Wang,
  • Huai-Gen Zhang,
  • Wei-Rong Yao,
  • Xi-Quan Zhang,
  • Hua-Zhang Tong,
  • Li Liu

摘要

Introduction

Primary squamous cell carcinoma of the colon is a rare malignancy, especially in the postpartum period. Currently, there are no recommended guidelines for this disease. BRAFV600E-mutated metastatic colorectal cancer occurs in approximately 8–12% of patients with colorectal cancer.

Case presentation

Herein, we report a case of a 37-year-old Chinese woman diagnosed with postpartum descending colon squamous cell carcinoma harboring the BRAFV600E mutation, which was treated with radical resection and adjuvant chemotherapy combined with targeted therapy. Eight months later, a new lesion was detected in the colon 40 cm away from the first mass. The patient was enrolled in a clinical trial but withdrew following two treatment cycles because of rapid disease progression. Subsequently, the patient died approximately 6 months after enrolling in the trial.

Conclusion

Squamous cell carcinoma of the colon, particularly in postpartum women, is uncommon and often associated with an advanced stage and poor prognosis. Presently, patients with colorectal cancer carrying the BRAFV600E mutation typically exhibit a low ratio, an advanced stage, and limited response to existing treatment approaches, resulting in a poor prognosis. Considerable emphasis and effort must be devoted to colonic squamous cell carcinoma, specifically cases harboring the BRAFV600E mutation.